The Synergistic, Amplifying Use of Micronized Purified Flavanoid Fraction, Proprietary Ceramide Emulsion, and Dermal Microdeformation Fuzzy Wale Compression Under Inelastic Compression for the Management of Venous Leg Ulcers

Main Article Content

Matthew Melin
Jennifer Reinders
Angie Wubben
Katie Cecconi


Pharmacology, Venous Ulcers, Wound Care


Abstract not available.


1. Levick JR, Michel CC. Microvascular fluid exchange and the revised Starling Principe. Cardiovascular Research 2010;87:198-210.

2. O’Donnell TF, Passman MA, et al. Management of venous leg ulcers: Clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg 2014;60:3S-59S.

3. Raffetto JD, Eberhardt RT, Dean SM, et al. Pharmacologic treatment to improve venous leg ulcer healing. J Vasc Surg:Venous and Lym Dis 2016;4:371-

4. Ulloa JH. Micronized purified flavanoid fraction (MPFF) for patients suffering from chronic venous disease: a review of new evidence. Adv Ther 2019 p.1-6.

5. Choi MJ, Maibach HI. Role of ceramides in barrier function of healthy and diseased skin. American Journal of Clinical Dermatology 2005;6:215-223.

6. Sugarman JL, Parish LC. Efficacy of a lipid-based barrier repair formulation in moderate-to-severe pediatric atopic dermatitis. Journal of Drugs in Dermatology 2009;8(12):1106-1111.

7. Ehmann S, Walker KJ, Bailey CM, et al. Experimental simulation study to assess pressure distribution of different applications applied over an innovative primary wound dressing. Wounds 2020 Epub August 17; 1-11.

8. Wiegand C, White R. Microdeformation in wound healing. Wound Rep Reg 2013;21:793-799.